Amundi Asset Management US’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$26.9M Sell
281,608
-18,100
-6% -$1.65M 0.02% 594
2020
Q4
$23.8M Buy
299,708
+13,780
+5% +$998K 0.02% 590
2020
Q3
$17.7M Buy
285,928
+30,688
+12% +$2M 0.02% 577
2020
Q2
$16.9M Sell
255,240
-38,316
-13% -$2.29M 0.02% 557
2020
Q1
$4.51M Buy
293,556
+25,552
+10% +$1.28M 0.01% 766
2019
Q4
$14.7M Buy
268,004
+2,296
+0.9% +$120K 0.02% 658
2019
Q3
$13M Buy
265,708
+29,680
+13% +$1.49M 0.02% 638
2019
Q2
$90.9M Buy
236,028
+41,216
+21% +$2.08M 0.07% 203
2019
Q1
$9.67M Sell
194,812
-16,556
-8% -$745K 0.01% 722
2018
Q4
$7.65K Sell
211,368
-18,636
-8% -$778K 0.01% 730
2018
Q3
$11.7M Sell
230,004
-76,628
-25% -$3.39M 0.02% 693
2018
Q2
$11.3M Sell
306,632
-23,052
-7% -$880K 0.02% 688
2018
Q1
$12.4M Buy
329,684
+28,144
+9% +$994K 0.02% 623
2017
Q4
$9.77M Buy
+301,540
New +$9.58M 0.02% 680

Other funds holding TECH

Amundi Asset Management US's TECH Position: Q1 2021 in Review

Amundi Asset Management US reduced its Bio-Techne (TECH) stake by 6% in Q1 2021, selling an estimated $1.65M and leaving 281,608 shares worth $26.9M. The position accounts for 0.02% of the portfolio, ranked #594.

Amundi Asset Management US first reported a position in TECH in Q4 2017 and has held it in 14 quarters since. The position peaked at $90.9M in Q2 2019. 471 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

  • Amundi Asset Management US held 281,608 shares of Bio-Techne worth $26.9M as of Q1 2021.
  • Amundi Asset Management US sold 18,100 Bio-Techne shares in Q1 2021, an estimated $1.65M.
  • Bio-Techne made up 0.02% of Amundi Asset Management US's portfolio in Q1 2021, its #594 holding.
  • Amundi Asset Management US first reported a position in Bio-Techne in Q4 2017 and has held it in 14 quarters since.
  • Amundi Asset Management US's Bio-Techne position peaked at $90.9M in Q2 2019.
  • 471 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.